LAPSES IN ASTHMA CONTROL IN PATIENTS WHO CONTINUED VS. DISCONTINUED OMALIZUMAB IN A REAL-WORLD SETTING.

被引：0
|
作者：
Sun, G.
Antonova, E.
Chang, E.
Broder, M.
Solari, P.
Zazzali, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2014年 / 113卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P80
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [1] LONGITUDINAL CHANGE IN ASTHMA SYMPTOM CONTROL IN PATIENTS WHO CONTINUED VS. DISCONTINUED OMALIZUMAB: RESULTS FROM THE XPORT STUDY.
    Antonova, J.
    Trzaskoma, B.
    Raimundo, K.
    Solari, P.
    Zazzali, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A37 - A37
  • [2] Physician assessment of asthma control in patients receiving omalizumab in a real-world setting
    Szabo, Melinda
    Chlumsky, Jan
    Maykut, Robert
    Georgiou, Panayiotis
    Chen, Chien-Wei
    Peachey, Guy
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [3] Omalizumab in the real-world: systematic review of asthma control outcomes reported by patients
    Nissen, Francis
    Humbert, Marc
    Gibson, Peter
    Kostikas, Konstantinos
    Jaumont, Xavier
    Olsson, Petter
    Alvares, Luisa
    Bousquet, Jean
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] An Assessment of Asthma Control in a Real-World Setting
    Holguin, F.
    Hanania, N. A.
    Pennington, E. J.
    Busse, W. W.
    Chiddarwar, H.
    Zigmont, E.
    Chornak, J.
    Nelson, G.
    Ortega, H.
    Camargo, C. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Braunstahl, Gert-Jan
    Chlumsky, Jan
    Peachey, Guy
    Chen, Chien-Wei
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [6] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Gert-Jan Braunstahl
    Jan Chlumský
    Guy Peachey
    Chien-Wei Chen
    Allergy, Asthma & Clinical Immunology, 9
  • [7] A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S53
  • [8] A REAL-WORLD ASSESSMENT OF OMALIZUMAB TREATMENT PATTERNS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Panettieri, R., Jr.
    Corren, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
  • [9] REDUCTIONS IN EXACERBATIONS IN PATIENTS WITH ALLERGIC (IGE-MEDIATED) ASTHMA RECEIVING OMALIZUMAB IN A REAL-WORLD SETTING
    Kuo, H. P.
    Canvin, J.
    Maykut, R.
    Bruce, J.
    Chen, C. W.
    Braunstahl, G. J.
    RESPIROLOGY, 2012, 17 : 11 - 11
  • [10] Severe asthma phenotypes in patients controlled with omalizumab: A real-world study
    Campo, Paloma
    Soto Campos, Gregorio
    Blanco Aparicio, Marina
    Moreira Jorge, Ana
    Gonzalez Exposito, Hector Manuel
    Quirce, Santiago
    Davila, Ignacio
    RESPIRATORY MEDICINE, 2019, 159
12345